205 related articles for article (PubMed ID: 9165371)
1. Dual effects of lisinopril on puromycin aminonucleoside nephrosis in unilaterally nephrectomized rats.
Shinosaki T; Takagawa I; Sunagawa N; Yonetani Y; Kurihara H
Jpn J Pharmacol; 1997 Apr; 73(4):337-45. PubMed ID: 9165371
[TBL] [Abstract][Full Text] [Related]
2. Effect of a specific endothelin receptor A antagonist and an angiotensin-converting enzyme inhibitor on glomerular mRNA levels for extracellular matrix components, metalloproteinases (MMP) and a tissue inhibitor of MMP in aminonucleoside nephrosis.
Ebihara I; Nakamura T; Tomino Y; Koide H
Nephrol Dial Transplant; 1997 May; 12(5):1001-6. PubMed ID: 9175058
[TBL] [Abstract][Full Text] [Related]
3. Temocapril, a long-acting non-SH group angiotensin converting enzyme inhibitor, modulates glomerular injury in chronic puromycin aminonucleoside nephrosis.
Zheng Y; Shirato I; Maeda A; Kobayashi N; Liao J; Shou I; Fukui M; Tomino Y
J Nephrol; 2002; 15(1):36-41. PubMed ID: 11936424
[TBL] [Abstract][Full Text] [Related]
4. Antiproteinuric effect predicts renal protection by angiotensin-converting enzyme inhibition in rats with established adriamycin nephrosis.
Wapstra FH; Van Goor H; Navis G; De Jong PE; De Zeeuw D
Clin Sci (Lond); 1996 May; 90(5):393-401. PubMed ID: 8665777
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin converting-enzyme inhibition restores glomerular glycosaminoglycans in rat puromycin nephrosis.
Herman-Edelstein M; Chagnac A; Nevo Z; Skutelsky E; Evron Y; Hirsch Y; Ben-Dor L; Schwartz I; Schwartz D; Weinstein T
Exp Toxicol Pathol; 2016 Nov; 68(10):543-552. PubMed ID: 27591087
[TBL] [Abstract][Full Text] [Related]
6. Addition of AT1 blocker fails to overcome resistance to ACE inhibition in adriamycin nephrosis.
Bos H; Henning RH; De Boer E; Tiebosch AT; De Jong PE; De Zeeuw D; Navis G
Kidney Int; 2002 Feb; 61(2):473-80. PubMed ID: 11849387
[TBL] [Abstract][Full Text] [Related]
7. Modulation of basement membrane component gene expression in glomeruli of aminonucleoside nephrosis.
Nakamura T; Ebihara I; Shirato I; Tomino Y; Koide H
Lab Invest; 1991 May; 64(5):640-7. PubMed ID: 2030578
[TBL] [Abstract][Full Text] [Related]
8. ACE inhibition preserves heparan sulfate proteoglycans in the glomerular basement membrane of rats with established adriamycin nephropathy.
Wapstra FH; Navis GJ; van Goor H; van den Born J; Berden JH; de Jong PE; de Zeeuw D
Exp Nephrol; 2001; 9(1):21-7. PubMed ID: 11053977
[TBL] [Abstract][Full Text] [Related]
9. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats.
Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY
Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817
[TBL] [Abstract][Full Text] [Related]
10. [Effects of human Cu, Zn-superoxide dismutase in aminonucleoside nephrosis--evaluation of the morphology and glomerular basement membrane anionic charge sites].
Higuchi A
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):767-75. PubMed ID: 2273594
[TBL] [Abstract][Full Text] [Related]
11. Glomerular epithelial detachment, not reduced charge density, correlates with proteinuria in adriamycin and puromycin nephrosis.
Whiteside C; Prutis K; Cameron R; Thompson J
Lab Invest; 1989 Dec; 61(6):650-60. PubMed ID: 2601299
[TBL] [Abstract][Full Text] [Related]
12. Morphometric changes in glomerular anionic sites during aminonucleoside nephrosis.
Washizawa K; Ishii K; Itoh N; Mori T; Akabane T; Shigematsu H
Acta Pathol Jpn; 1989 Sep; 39(9):558-65. PubMed ID: 2596296
[TBL] [Abstract][Full Text] [Related]
13. Suppression of proteinuria by dipyridamole in rats with aminonucleoside nephropathy.
Nagase M; Kumagai H; Honda N
Ren Physiol; 1984; 7(4):218-26. PubMed ID: 6473895
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis.
Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y
J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms underlying the ameliorative property of lisinopril in progressive mesangioproliferative nephritis.
Shinosaki T; Miyai I; Nomura Y; Kobayashi T; Sunagawa N; Kurihara H
Nephron; 2002 Aug; 91(4):719-29. PubMed ID: 12138278
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of antioxidant enzyme suppression and proteinuria in cyclosporin-treated puromycin nephrosis.
Wang JS; Yang AH; Chen SM; Young TK; Chiang H; Liu HC
Nephron; 1993; 65(3):418-25. PubMed ID: 8289993
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of radical scavenger edaravone against puromycin nephrosis.
Matsumura H; Ashida A; Hirano K; Nakakura H; Tamai H
Clin Nephrol; 2006 Dec; 66(6):405-10. PubMed ID: 17176911
[TBL] [Abstract][Full Text] [Related]
18. Retinoids as a potential treatment for experimental puromycin-induced nephrosis.
Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ
Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of 35sulfate into the glomerular basement membrane in puromycin aminonucleoside nephrosis.
Garin EH; Boggs KP; Burke FC
Int J Pediatr Nephrol; 1985; 6(2):117-20. PubMed ID: 4030221
[TBL] [Abstract][Full Text] [Related]
20. The effect of captopril on urinary protein excretion in puromycin aminonucleoside nephrosis in rats.
Trachtman H; Zavilowitz B; Bennett B; Goldsmith DI
Pediatr Res; 1985 Aug; 19(8):828-34. PubMed ID: 3898001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
